For 25 years, Microline Surgical has advanced the field of minimally invasive surgery by delivering precision surgical instruments that enable surgeons across the globe to perform highly complex procedures with fewer complications and better patient outcomes and at a lower cost compared with open surgical techniques. Today, Microline marks its 25th anniversary with nearly $50 million
in revenue, sales offices in Amsterdam, Paris, Tokyo and Hong Kong, and customers in 65 countries.

Microline Surgical designs, develops, manufactures, and markets advanced
laparoscopic instruments used across a broad range of surgical disciplines, including
General, Gynecologic, Bariatric, Head and Neck, Urologic , and Cardiac surgery
procedures. The company holds approximately 70 patents, employs over 200
collaborators and occupies a 50,000 square foot facility at its worldwide headquarters
located in Beverly, Mass. Microline’s products are distributed worldwide through a
network of over 70 independent distributors in North and South America, Europe, the
Middle East and Asia. Over the past 17 years, Microline has achieved an impressive 25
percent compound annual growth rate (CAGR) in revenues, which Microline Chairman
and CEO Dr. Jean-Luc Boulnois attributes to its entrepreneurial spirit and dedication to
advancing surgical care.